Showing results (1741-1750 of 2,011) with videos related to

Sort By:
Pageof 202
The American Journal of Pathology|November 30, 2005
Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine modelRobert S Stearman, Lori Dwyer-Nield, Laura Zerbe, et al.
Plos One|October 12, 2012
Earliest porotic hyperostosis on a 1.5-million-year-old hominin, olduvai gorge, TanzaniaManuel Domínguez-Rodrigo, Travis Rayne Pickering, Fernando Diez-Martín, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 4, 2011
Oral iloprost improves endobronchial dysplasia in former smokersRobert L Keith, Patrick J Blatchford, John Kittelson, et al.
Agronomy for Sustainable Development|September 6, 2021
Transformation of coffee-growing landscapes across Latin America. A reviewCelia A Harvey, Alyssa A Pritts, Marie J Zwetsloot, et al.
Plos One|September 13, 2012
Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission riskMassaro W Ueti, Robert H Mealey, Lowell S Kappmeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumorsSamir E Witta, Daniel L Gustafson, A Scott Pierson, et al.
Lung Cancer (Amsterdam, Netherlands)|November 30, 2024
The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutationsTejas Patil, Dexiang Gao, Alexander Watson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 2019
HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinibY Wang, T Jiang, Z Qin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2024
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung CancerDavid R Spigel, Afshin Dowlati, Yuanbin Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 9, 2019
Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium ExperienceBadi El Osta, Madhusmita Behera, Sungjin Kim, et al.
Pageof 202